Yang, Lingfeng

Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials

Vandenberghe, R., Rinne, J. O., Boada, M., Katayama, S., Scheltens, P., Vellas, B., Tuchman, M., Gass, A., Fiebach, J. B., Hill, D., et al. (2016) · Alzheimer's Research & Therapy

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 304

Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK

Weiss, T., Yang, L., Carr, R. D., Pal, S., Sawhney, B., Boggs, R., Rajpathak, S., & Iglay, K. (2022) · BMJ Open Diabetes Research & Care

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 152

Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States

Weiss, T., Carr, R. D., Pal, S., Yang, L., Sawhney, B., Boggs, R., Rajpathak, S., & Iglay, K. (2020) · Patient Preference and Adherence

Diabetes Treatment and ManagementMedication Adherence and Compliance

Cited by 126

Real-World Genetic Testing Patterns in Metastatic Castration-Resistant Prostate Cancer

Shore, N., Ionescu-Ittu, R., Yang, L., Laliberté, F., Mahendran, M., Lejeune, D., Yu, L., Burgents, J., Duh, M. S., & Ghate, S. R. (2021) · Future Oncology

PARP inhibition in cancer therapyProstate Cancer Treatment and Research

Cited by 36

Secondary metformin monotherapy failure in individuals with type 2 diabetes mellitus

Weiss, T., Iglay, K., Gulati, T., Rajpathak, S., Yang, L., & Blonde, L. (2021) · BMJ Open Diabetes Research & Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 6